These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15906063)

  • 21. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between leptin G2548A gene polymorphism and Behçet's disease.
    Aydin F; Kara N; Senturk N; Gunes S; Canturk MT; Bagci H; Bek Y; Turanli AY
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):68-71. PubMed ID: 17207170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urokinase plasminogen activator receptor levels in Behcet's disease.
    Birengel S; Yalçındağ FN; Yalçındağ A; Sahli E; Batıoğlu F
    Thromb Res; 2011 Sep; 128(3):274-6. PubMed ID: 21470667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D status in patients with Behcet's Disease.
    Karatay S; Yildirim K; Karakuzu A; Kiziltunc A; Engin RI; Eren YB; Aktas A
    Clinics (Sao Paulo); 2011; 66(5):721-3. PubMed ID: 21789370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
    Balkarli A; Kucuk A; Babur H; Erbasan F
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
    Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
    Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in cerebral and ocular hemodynamics in Behçet's disease assessed by color-coded duplex sonography.
    Yilmaz S; Akarsu C
    Eur J Radiol; 2006 Apr; 58(1):102-9. PubMed ID: 16466883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
    Ataş H; Cemil BC; Canpolat F; Gönül M
    Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Color doppler imaging of ocular hemodynamic changes in Behçet's disease.
    Caça I; Nazaroğlu H; Unlü K; Cakmak SS; Ari S; Sakalar YB
    Jpn J Ophthalmol; 2004; 48(2):101-5. PubMed ID: 15060789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of interleukin-2 receptor in ocular Behçet's disease.
    BenEzra D; Maftzir G; Kalichman I; Barak V
    Am J Ophthalmol; 1993 Jan; 115(1):26-30. PubMed ID: 8420374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphonuclear leukocyte elastase levels in patients with Behçet's disease.
    Değer O; Orem A; Akyol N; Bahadir S; Yildirmis S
    Clin Chim Acta; 1995 May; 236(2):129-34. PubMed ID: 7554279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
    Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
    Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro Candidacidal effect of polymorphonuclear neutrophils of Behçet's patients with or without ocular involvement.
    Tekeli A; Tekeli O; Ozdemir O
    APMIS; 2001 Feb; 109(2):108-12. PubMed ID: 11398991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum prolactin levels in Behçet's disease.
    Apaydin KC; Duranoglu Y; Ozgürel Y; Saka O
    Jpn J Ophthalmol; 2000; 44(4):442-5. PubMed ID: 10974304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
    Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of serum resistin levels in patients with ocular and non-ocular Behçet's disease.
    Yalçindag FN; Yalçindag A; Batioglu F; Caglayan O; Kisa U; Ozdemir O
    Can J Ophthalmol; 2008 Aug; 43(4):473-5. PubMed ID: 18711464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.